LYMPH DUCT FORMATION REVELLENT AND LYMPH DUCT FORMATION DEFECT PREVENTION AND TREATMENT COMPOSITION USING THE SAME

摘要

PURPOSE: A lymphoduct generation inducer containing erythropoietin is provided to induce lymphduct through Akt/ERK pathway in human lymph vascular epithelial cells. CONSTITUTION: A lymphoduct generation inducer contains erythropoietin as an active ingredient. A composition for preventing or treating lymphedema contains erythropoietin as an active ingredient. A composition for preventing or treating lymphoduct loss or lymphopenia contains the erythropoietin as an active ingredient.